Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis.
Majdoub M, Yanagisawa T, Quhal F, Laukhtina E, von Deimling M, Kawada T, Rajwa P, Bianchi A, Pallauf M, Mostafaei H, Chlosta M, Pradere B, Karakiewicz PI, Schmidinger M, Rub R, Shariat SF. Majdoub M, et al. Among authors: quhal f. Int J Cancer. 2024 Apr 1;154(7):1309-1323. doi: 10.1002/ijc.34793. Epub 2023 Nov 27. Int J Cancer. 2024. PMID: 38009868
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis.
Mori K, Pradere B, Quhal F, Katayama S, Mostafaei H, Laukhtina E, Schuettfort VM, D'Andrea D, Egawa S, Bensalah K, Schmidinger M, Powles T, Shariat SF. Mori K, et al. Among authors: quhal f. Cancer Treat Rev. 2021 Sep;99:102242. doi: 10.1016/j.ctrv.2021.102242. Epub 2021 Jun 12. Cancer Treat Rev. 2021. PMID: 34153830 Free article.
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
Yanagisawa T, Mori K, Katayama S, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Motlagh RS, Aydh A, König F, Grossmann NC, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: quhal f. Int J Clin Oncol. 2022 Jan;27(1):59-71. doi: 10.1007/s10147-021-02061-0. Epub 2021 Nov 10. Int J Clin Oncol. 2022. PMID: 34757531 Free PMC article. Review.
The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis.
Mori K, Quhal F, Yanagisawa T, Katayama S, Pradere B, Laukhtina E, Rajwa P, Mostafaei H, Sari Motlagh R, Kimura T, Egawa S, Bensalah K, Karakiewicz PI, Schmidinger M, Shariat SF. Mori K, et al. Among authors: quhal f. Int Immunopharmacol. 2022 Jul;108:108720. doi: 10.1016/j.intimp.2022.108720. Epub 2022 Mar 24. Int Immunopharmacol. 2022. PMID: 35339843 Free article. Review.
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery.
Pallauf M, König F, D'Andrea D, Laukhtina E, Mostafaei H, Motlagh RS, Quhal F, Aydh A, Yanagisawa T, Kawada T, Rajwa P, Lusuardi L, Soria F, Karakiewicz PI, Rouprêt M, Rink M, Lotan Y, Margulis V, Singla N, Xylinas E, Shariat SF, Pradere B. Pallauf M, et al. Among authors: quhal f. Front Oncol. 2022 Jul 1;12:907975. doi: 10.3389/fonc.2022.907975. eCollection 2022. Front Oncol. 2022. PMID: 35847838 Free PMC article.
Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysis.
Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Motlagh RS, Laukhtina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Majdoub M, Pradere B, Abufaraj M, Moschini M, Karakiewicz PI, Iwatani K, Miki J, Kimura T, Shariat SF. Yanagisawa T, et al. Among authors: quhal f. BJU Int. 2023 Jun;131(6):643-659. doi: 10.1111/bju.15944. Epub 2023 Jan 13. BJU Int. 2023. PMID: 36479820 Review.
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.
Mori K, Miura N, Mostafaei H, Quhal F, Sari Motlagh R, Pradere B, Kimura S, Kimura T, Egawa S, Briganti A, Karakiewicz PI, Shariat SF. Mori K, et al. Among authors: quhal f. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9. Prostate Cancer Prostatic Dis. 2020. PMID: 32152435
135 results